ECHONOF III trial - participants with isolated, primary and non metastatic NOF

The ECHONOF III trial aims to recruit patients presenting with isolated, primary, non-metastatic
fractured neck of femur, where surgery is expected within 48 hours after hospital admission. Depend on randomisation outcome, 50% of the trial participants will receive trial intervention. The intervention is not a stand-alone product per se, but rather an ultrasound examination of the heart. In addition to clinical
evaluation, participants randomised to the focused cardiac ultrasound group will receive a preoperative focused cardiac ultrasound performed prior to surgery, following The University of Melbourne iHeartScan protocol. The control group will consist of current standard of care practice which does not involve routine
use of preoperative focused cardiac ultrasound.
The study dataset may also include a set of QoL surveys, such as PostopQRS survey, clinical frailty scale, ED-5D-5L and Lawton Brody IADL scale.

Please note that the study dataset may only be available once the ECHONOF III trial is completed and concluded. Assessing and utilising the ECHONOF III dataset for research purposes may require additional ethical approval.